Efficacy of Adjuvant Mitotane Treatment in Prolonging Recurrence-Free Survival in Patients With Adrenocortical Carcinoma at Low-Intermediate Risk of Recurrence.
Phase of Trial: Phase III
Latest Information Update: 10 May 2017
At a glance
- Drugs Mitotane (Primary)
- Indications Adenocarcinoma
- Focus Therapeutic Use
- Acronyms ADIUVO
- 04 May 2017 Planned End Date changed from 1 Oct 2016 to 1 Dec 2020.
- 04 May 2017 Planned primary completion date changed from 1 Dec 2013 to 1 Dec 2018.
- 18 Jun 2013 New source identified and integrated (United Kingdom Clinical Research Network: 14759).